
ROLE OF THE APOB GENE POLYMORPHISM (c.12669G>A,
p.Gln4154Lys) IN CORONARY ARTERY DISEASE IN
THE INDIAN PUNJABI POPULATION Sharma R1,*, Mahajan M2, Singh B1, Singh G3, Singh P3 *Corresponding Author: Ritu Sharma, Department of Biochemistry, Government Medical College, Circular
Road, Amritsar-143001, Punjab, India; Tel.: +91-183-257-3637; Fax: +91-183-242-6506: E-mail: ritu_gmc@
rediffmail.com page: 35
|
INTRODUCTION
Apolipoprotein B (apoB) is the predominant apolipoprotein
found in atherogenic low-density lipoprotein
(LDL). Raised serum apoB levels are associated
with increased risk of coronary artery disease (CAD)
[1-3]. Similar results have also been reported from our
laboratory [4,5]. The gene encoding for the APOB has
been cloned and sequenced. It is 45 kb in length with
29 exons [6]. The APOB gene is known to have several sequences which are the recognition sites for various
restriction enzymes. Polymorphism in the APOB gene
with respect to the EcoR1 restriction site exists due to
a change in guanidine to adenine at exon 29, leading
to the substitution of glutamine for lysine at position
4154 in the apoB polypeptide product [7]. This nucleotide
change leads to loss of the EcoR1 restriction site.
The wild type and the mutated alleles are designated as
R+ and R–, respectively. The frequency of the R– allele
has been reported to be more prevalent in CAD patients
as compared to normal subjects in some but not
all populations, thus suggesting that subjects having
the R– allele are probably more susceptible to CAD
development [8-13]. Some investigators reported the
positive association of the R– allele with raised serum
lipid levels [12], while others reported no such association
[11]. The available reports indicate considerable
variation in linking APOB gene polymorphism
(c.12669G>A,p.Gln4154Lys) with CAD risk in different
populations. The present study aimed to investigate
the role of this APOB gene polymorphism with
CAD in the Indian Punjabi population. Punjabi’s are
known to consume a fat-rich diet and are genetically
more prone to CAD development. The present study
would help in delineating a subset population at higher
or lower risk of CAD. To the best of our knowledge,
no such study has so far been done on the native Indian
Punjabi population.
|
|
|
|



 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|